| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/12/2004 | WO2003013424A3 Use of r-nsaid compounds for anti-hiv treatment |
| 02/12/2004 | WO2003008365A3 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 02/12/2004 | WO2002076507A3 Uses of opg ligand to modulate immune responses |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002030406A3 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040029970 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 02/12/2004 | US20040029964 Calcium formate for use as a dietary supplement |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029949 Antisecretory agents; potassium channel moderators; irritable bowel syndrome |
| 02/12/2004 | US20040029947 R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease |
| 02/12/2004 | US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029924 Administering by mouth; enteric cellulose coated pellets; gastrointestinal disorders |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029917 Benzosuberonylpiperdine compounds as analgesics |
| 02/12/2004 | US20040029916 Antiarthritic agents; skin disorders; Crohn's disease |
| 02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |
| 02/12/2004 | US20040029901 Obesity therapy; administering orlistat |
| 02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029873 Antiinflammatory agents; Alzheimer's disease; atherosclerosis; inflammatory bowel diseases; antiarthritic agents |
| 02/12/2004 | US20040029870 Antiinflammatory agents |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029853 Therapy for gastrointestinal disorders |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029828 Homeostasis-maintaining agents |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029793 Genetic engineering; antibodies; antiinflammatory agents, circulation diseases, anticancer agents, antidiabetic agents, gastrointestinal disorders |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028689 Gastrointestinal diosrders |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028672 Calibration of infection therapy measuring proteinase; antiulcer agents; wound healing agent |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028623 Mixture containin glutathione, sodium mercaptoethanesulfonic acid, diethyldithiocarbamic acid, sodium thiosulfate, acetylcysteine, cytochromes, and cysteamine |
| 02/12/2004 | DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | DE10233229A1 Pharmazeutische Zusammensetzung zur Senkung des Triglyceridspiegels A pharmaceutical composition for lowering triglyceride levels |
| 02/12/2004 | CA2495447A1 Anti-microbial compositions and methods of using same |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494408A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | CA2494308A1 Methods of use of compounds with preptin function |
| 02/12/2004 | CA2494284A1 Methods for treatment and prevention of gastrointestinal conditions |
| 02/12/2004 | CA2494146A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | CA2492830A1 Pyrrolidine derivatives as tryptase inhibitors |
| 02/12/2004 | CA2492750A1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1388340A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 02/11/2004 | EP1388327A1 Artificial kidney having function of metabolizing protein and mehtod of constructing the same |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387829A1 Novel pyridinone and related heterocyclic derivatives |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387687A2 Novel use |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387665A2 System for delivering cosmetics and pharmaceuticals |
| 02/11/2004 | EP1387620A1 Method for producing a nutrition additive, an additive and its use |
| 02/11/2004 | EP1328282A4 Efficient method for producing compositions enriched in anthocyanins |
| 02/11/2004 | EP1165491B1 Lta4 hydrolase inhibitors |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1107776B1 Dry extract of henna, method for producing said extract and use of the same |
| 02/11/2004 | EP1086113B1 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 02/11/2004 | EP1032561B1 Substituted oximes as neurokinin antagonists |
| 02/11/2004 | EP0994716B1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474828A Erythromycin derivative having novel crystal structures and process for their production |